Search results
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 10 hours agoNovavax will receive as much as $1.2 billion as part of a Covid vaccine licensing deal with Sanofi.
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 17 hours agoNovavax will also be entitled to a further $200 million in additional launch and sales milestone...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
FOX 23 News Albany· 20 hours agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-& ...
"FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about...
CBS News· 12 hours agoMore than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing...
Novavax’s 146% Surge Delivers ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg· 10 hours agoHave a confidential tip for our reporters? Novavax Inc.’s record one-day gain is forcing some short...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg· 19 hours agoHave a confidential tip for our reporters? Novavax Inc. shares surged after the company signed a...
Why Is Novavax (NVAX) Stock Up 118% Today?
InvestorPlace· 14 hours agoNovavax (NASDAQ:NVAX) stock is on the rise Friday after the biotechnology company announced a deal with Sanofi (NASDAQ:SNY) alongside its first-quarter earnings report. The ...
Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi
Morningstar· 15 hours agoShares of Novavax surged after the company disclosed a $1.4 billion licensing deal with Sanofi. The stock was up 72% at $7.66 in premarket trading on Friday. The ...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 5 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 16 hours agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...